Publicaciones en colaboración con investigadores/as de Mayo Clinic (13)

2016

  1. Immunotherapy in colorectal cancer: What have we learned so far?

    Clinica Chimica Acta, Vol. 460, pp. 78-87

2014

  1. Clinical relevance of KRAS mutations in codon 13: Where are we?

    Cancer Letters

  2. Corrigendum to Clinical relevance of KRAS mutations in codon 13: Where are we? [Cancer Lett. 343 (1 (2013) 1-5]

    Cancer Letters

2013

  1. Alcohol consumption on pancreatic diseases

    World Journal of Gastroenterology, Vol. 19, Núm. 5, pp. 638-647

  2. Epigenetic regulation of autophagy by the methyltransferase G9a

    Molecular and Cellular Biology, Vol. 33, Núm. 20, pp. 3983-3993

  3. Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation

    Journal of Biological Chemistry, Vol. 288, Núm. 17, pp. 11786-11794

  4. Molecular markers in pancreatic cancer diagnosis

    Clinica Chimica Acta, Vol. 418, pp. 22-29

  5. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells

    Oncogenesis, Vol. 2

2012

  1. Adjuvant and neoadjuvant treatment in pancreatic cancer

    World Journal of Gastroenterology, Vol. 18, Núm. 14, pp. 1565-1572

  2. KRAS assay selection: Sensitivity and accuracy in clinical application

    Molecular Biology Reports, Vol. 39, Núm. 3, pp. 2467-2470

  3. Mouse models of pancreatic cancer

    World Journal of Gastroenterology, Vol. 18, Núm. 12, pp. 1286-1294

  4. Spontaneous regression of pancreatic cancer: Real or a misdiagnosis?

    World Journal of Gastroenterology, Vol. 18, Núm. 23, pp. 2902-2908

  5. c-Met in pancreatic cancer stem cells: Therapeutic implications

    World Journal of Gastroenterology, Vol. 18, Núm. 38, pp. 5321-5323